some agents have shown reduction in major adverse cardiovascular events in specific populations [28] [29] Renal protection : slowing of diabetic kidney disease progression across the class Weight loss : modest reduction in body weight Blood pressure reduction : mild antihypertensive effect SGLT2 inhibitors do carry risks including genital mycotic infections and, rarely, euglycaemic diabetic ketoacidosis
Start Small To Feel Your Best Using small doses of GLP-1 offers a thoughtful way to start managing appetite and weight without the stronger effects of full-dose medicine
Heres a look at many of the ways using a GLP-1 can affect your skin
A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is part of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1
endotoxin (LAL) per USP
Does this include Ozempic